Based on the analysis of Stryker's profitability, liquidity, and operating efficiency, Stryker is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December. At this time, Stryker's Property Plant And Equipment Net is quite stable compared to the past year. Net Debt is expected to rise to about 10.5 B this year, although the value of Accumulated Other Comprehensive Income is projected to rise to (395.2 M). Key indicators impacting Stryker's financial strength include:
The essential information of the day-to-day investment outlook for Stryker includes many different criteria found on its balance sheet. An individual investor should monitor Stryker's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Stryker.
Cash And Equivalents
2.46 Billion
Stryker
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Stock Based Compensation
Dividends Paid
Sale Purchase Of Stock
Change To Account Receivables
Change To Liabilities
Change To Netincome
Other Cashflows From Investing Activities
Total Cashflows From Investing Activities
Investments
Change Receivables
Net Borrowings
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Operating Activities
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Total Current Assets
Short Term Debt
Intangible Assets
Accounts Payable
Property Plant And Equipment Gross
Accumulated Other Comprehensive Income
Short Term Investments
Current Deferred Revenue
Good Will
Common Stock Total Equity
Common Stock
Other Liab
Other Assets
Long Term Debt
Property Plant Equipment
Net Tangible Assets
Retained Earnings Total Equity
Capital Surpluse
Non Current Liabilities Other
Accumulated Depreciation
Deferred Long Term Asset Charges
Long Term Debt Total
Long Term Investments
Short Long Term Debt
Cash And Equivalents
Net Invested Capital
Net Working Capital
Depreciation And Amortization
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Selling General Administrative
Research Development
Net Income Applicable To Common Shares
Net Income From Continuing Ops
Non Recurring
Non Operating Income Net Other
Tax Provision
Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Stryker Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Stryker's financial statements are interrelated, with each one affecting the others. For example, an increase in Stryker's assets may result in an increase in income on the income statement.
Stryker competes with Boston Scientific, Abbott Laboratories, Medtronic PLC, DexCom, and Edwards Lifesciences. Stryker Corporation operates as a medical technology company. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. Stryker Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 46000 people.
Comparative valuation techniques use various fundamental indicators to help in determining Stryker's current stock value. Our valuation model uses many indicators to compare Stryker value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stryker competition to find correlations between indicators driving Stryker's intrinsic value. More Info.
Stryker is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Stryker is roughly 2.65 . At this time, Stryker's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Stryker by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Stryker Systematic Risk
Stryker's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Stryker volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Stryker correlated with the market. If Beta is less than 0 Stryker generally moves in the opposite direction as compared to the market. If Stryker Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Stryker is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Stryker is generally in the same direction as the market. If Beta > 1 Stryker moves generally in the same direction as, but more than the movement of the benchmark.
Stryker Thematic Clasifications
Stryker is part of several thematic ideas from Healthcare to Obamacare Repeal. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Stryker Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Stryker's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Stryker growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Stryker help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Stryker. We use our internally-developed statistical techniques to arrive at the intrinsic value of Stryker based on widely used predictive technical indicators. In general, we focus on analyzing Stryker Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Stryker's daily price indicators and compare them against related drivers.
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.2
Dividend Share
3.2
Earnings Share
9.33
Revenue Per Share
57.728
Quarterly Revenue Growth
0.119
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.